[AP]
Experts stress HPV vaccination and regular screening as vital to combat cervical cancer, a disease affecting millions globally. Speaking during Cervical Cancer Awareness Month, specialists from the University of Athens underlined that early detection significantly improves survival rates.
The WHO estimates that some 660,000 women were diagnosed with cervical cancer in 2022, with 94% of fatalities occurring in low- and middle-income countries. Infection with high-risk HPV types accounts for 95% of cases, but vaccination for girls aged 9-14 and regular Pap or HPV testing can prevent its progression.
In Greece, expanded vaccination programs now include boys and young adults, alongside free screenings for women aged 21-65. The initiative has already screened over 20,000 women, promoting early intervention.
WHO aims to eliminate cervical cancer by 2120 through its 90-70-90 goals for vaccination, screening, and treatment access.